Niaspan, an FDA-approved drug, limits disease progression in lab models of Alzheimer's disease.
Combining niacin, or vitamin B3, with chemotherapy, helped slow the progression and increase life span in mouse models of glioblastoma.
NAPRT1, a gene that encodes an enzyme involved in vitamin B3 metabolism, may be a risk factor for schizophrenia. Knocking out the gene in zebrafish models, researchers discovered brain development became impaired. Without NAPRT1, the fish brains failed to divide symmetrically, which is significant as defects in the corpus callosum have been identified in those with schizophrenia.
A retrospective analysis finds a correlation between sleep disorders and a lack of essential vitamins and minerals.
Dietary Niacin can help boost levels of a compound associated with DNA repair, a new study reports.
